Score breakdown
Strengths & weaknesses
- Long record: certificate files on swisschems.is date back to September 2018
- Lab reports now link to Freedom Diagnostics PDFs you can open at the lab's own address
- Published shipping table: USPS 3-5 business days in the US, FedEx overnight and 2-day options
- Took retatrutide and tirzepatide down between 23 June and 10 October 2026
- FDA warning letter 695663 (10 Dec 2024); retatrutide was still on sale in June 2026
- Lists orforglipron, the drug in Lilly's FDA-approved Foundayo, in a 6 mg strength Lilly does not sell
- Finnrick: 4 of 10 samples passed; 47% rating, #447 of 457 vendors (read 10 Oct 2026)
- No Swiss Chems record in our Janoshik (337 readable reports, 364 indexed) or Kovera (1,828) mirrors
- A lookalike, swisschemzlab.com, claims to be its new home; swisschems.is says nothing about it
- A September 2026 Reddit complaint says support warned a buyer off a chargeback
- Its referral link sent visitors to the refund and return policy page instead of the shop on 12 and 13 October 2026
What it sells
15 PEPTIDES WE COVERShipping & payment
FROM PUBLISHED POLICY AND USER REPORTSAudit notes
FROM THE BENCHWhich Swiss Chems site is real?
swisschems.is. Every public record we checked on 10 October 2026 ties the Swiss Chems name to that domain. Nothing outside swisschemzlab.com itself supports the move it claims. Type swisschems.is yourself; on this evidence we would not pay swisschemzlab.com.
| swisschems.is | swisschemzlab.com | swisschems.com | |
|---|---|---|---|
| Registered | 25 June 2020 (RDAP) | 13 September 2026 (RDAP) | 25 August 2018 |
| Status on 10 Oct 2026 | Live store | Live store | Parked |
| What it says | "Est. 2018 — USA" on its about page | "Swiss Chems now operates at SwissChemzLab.com" | nothing |
| Support email | support@swisschems.is | support@swisschemzlab.com | n/a |
| Payment shown | card, bank transfer (ACH, Zelle, Interac), seven cryptocurrencies | crypto only, 10% crypto discount | n/a |
| Named in FDA letter 695663 | yes, site and email | no | no |
| Listed on Finnrick | yes | no | no |
| First archive capture | not retrievable on 10 Oct | 13 Sep 2026 | 23 Aug 2019 |
What points to swisschems.is as the original:
- FDA's letter. The December 2024 letter went to "Swisschems" at 42 Broadway, New York, by email to support@swisschems.is, and cites https://swisschems.is/ as the website reviewed.
- The file history. Our mirror of the shop's certificate page, crawled in May 2026, holds 89 images served from swisschems.is upload folders dated September 2018 to February 2026. A 2018 start fits the "Est. 2018" claim and the 2018 swisschems.com registration. The .is domain came later, in 2020, and we cannot tie swisschems.com's past owner to either current site.
- Shared files. swisschemzlab.com's test-results page loads its certificate images from swisschems.is servers. Its newest reports carry the date 13 September 2026, the day the domain was registered.
What contradicts swisschemzlab.com's account:
- Its FDA explainer says semaglutide and retatrutide "will not be returning" after the 2024 letter. Our 23 June 2026 capture of swisschems.is recorded "Retatrutide (LY-3437943)" in 5, 10, 20 and 30 mg, $149.95 to $259.95.
- It names Janoshik as its "principal" lab. swisschems.is's own FAQ says the same ("principally Janoshik Analytical"), so that claim does not separate the two sites. What fits neither is the paperwork: swisschems.is's results page links Freedom Diagnostics reports for its 2026 lots and does not mention Janoshik (read 12 October 2026), and our Janoshik mirror holds no Swiss Chems report.
- It runs on different hosting (Ultahost name servers against Cloudflare) and asks for crypto only.
What we cannot tell is whether the same people control both domains. swisschemzlab.com may be run by someone else using the name, or be a fallback the owner has not announced. We are not calling it a scam, and we have no record of anyone losing money to it. We link only to swisschems.is.
Is Swiss Chems legit?
Swiss Chems scores 46/100 on public data, down from the 78 our May 2026 preview gave it. It is a long-running shop: certificate files on swisschems.is date back to September 2018, and its newest lab reports open at the lab's own address. Its testing and regulatory record count against it.
- Independent tests. Finnrick recorded 4 passes in 10 samples, a 47% rating, ranked #447 of 457 vendors (read 10 October 2026). Our Janoshik and Kovera mirrors hold no Swiss Chems reports.
- FDA. Warning letter 695663 of 10 December 2024 named semaglutide and retatrutide. Our 23 June 2026 price capture still recorded retatrutide on sale; by 10 October it was gone.
- Current listings. swisschems.is lists orforglipron, the active ingredient of Lilly's FDA-approved Foundayo, as "6mg / 90caps" for $198.95. It also lists prescription-only drugs such as tamoxifen, letrozole and sildenafil as "research" capsules.
Our advice: skip Swiss Chems for peptides if independent testing decides your purchase. If you still order, type swisschems.is yourself and match the lot on your bottle to a report on the lab's own server. For a vendor with a deep, independently checkable record, Ion Peptide holds the largest clean Kovera set in our mirror. The scoring table shows how we reached 46.
What do Swiss Chems' lab reports show?
The shop's test-results page listed 94 reports on 10 October 2026. The newest, dated 23-24 September 2026, link to PDFs on Freedom Diagnostics' server, for example the NAD+ 100 mg report for lot 2607EDNA: 99.89% purity, 100.51 mg net content, client "Swiss Chems".
| Source | What it shows |
|---|---|
| Finnrick, read 10 Oct 2026 | 10 samples of ipamorelin, BPC-157 and CJC-1295, tested 1 Apr 2025 to 28 Apr 2026: 4 pass, 6 fail, 47%, #447 of 457 |
| Our mirror of the shop's certificates (89, crawled May 2026) | Identity reported on every page we extracted; most retests dated March-April 2026 |
| Our Janoshik (337 readable reports, 364 indexed) and Kovera (1,828) mirrors | No Swiss Chems reports |
| Freedom Diagnostics, BPC-157 capsules, lot J26HGBPC | 0.64 mg against a 0.5 mg label, 128% |
The BPC-157 capsule lot came in 28% over its 0.5 mg label, outside the ±10% band many specifications allow.
Three cautions on the shop's own paperwork. Some newer reports name the client as "IMT", not Swiss Chems, so the report alone does not prove the sample came from this shop. In May 2026 we found Methylene Blue certificates filed under the Clomiphene capsule listings. We read that as a filing error. And the shop's FAQ says batches go principally to Janoshik Analytical, while its results page links Freedom Diagnostics reports and does not mention Janoshik. Either way, match the product and lot on every report to your bottle.
We weigh Finnrick's six failures above the shop's own clean reports, because the vendor chooses which sample a vendor-commissioned report tests.
What did the FDA warning letter cover?
FDA's December 2024 letter named semaglutide and retatrutide. Both are now off the site, and swisschems.is has since added orforglipron.
| Date | Event | Source |
|---|---|---|
| 10 Dec 2024 | FDA warning letter 695663 names semaglutide and retatrutide, the swisschems.is product pages, and Facebook and Instagram posts ("Semaglutide, a key player in metabolic and weight regulation is now available") | FDA |
| 1 Apr 2026 | FDA approves Lilly's Foundayo (orforglipron) for weight management | FDA |
| 15 Jun 2026 | swisschems.is publishes "Orforglipron 6mg / 90caps", $198.95 (page metadata) | product page |
| 23 Jun 2026 | Our price capture records retatrutide and tirzepatide on swisschems.is | our capture |
| 10 Oct 2026 | Retatrutide and tirzepatide product addresses no longer show a product; site search returns no semaglutide, retatrutide or tirzepatide | our check |
| 12 Oct 2026 | FDA's page for letter 695663 still shows no response or close-out letter; the shop's store listing still carries orforglipron 6mg / 90caps at $198.95, in stock; searches for semaglutide, retatrutide and tirzepatide still return nothing | FDA, our check |
Orforglipron is the exposure to watch. It is the active ingredient of an approved prescription drug, Lilly owns it, and Lilly has spent 2026 suing online sellers of its other GLP-1 molecules (see Lilly's peptide lawsuits). Lilly sells Foundayo tablets in 0.8 to 17.2 mg strengths; 6 mg is not one of them. We know of no FDA letter or Lilly suit naming Swiss Chems over orforglipron as of 12 October 2026. The wider pattern is on our enforcement timeline.
Payments, shipping and refunds
| Item | What swisschems.is says (10 Oct 2026) |
|---|---|
| Payment | US-issued Visa and Mastercard; bank transfer through a payment processor (Plaid ACH, Zelle, Interac, Coinbase); seven cryptocurrencies through NowPayments, including Bitcoin and Ethereum |
| US shipping | USPS flat rate 3-5 business days; free-shipping orders 5-7; FedEx overnight and 2-day where eligible |
| International | USPS, 2-3 weeks (1-2 to Canada) |
| Returns | "30-day hassle-free returns on unopened products" (product pages) |
| Support | support@swisschems.is and a US phone number |
These are the shop's own terms. Its refund-policy and terms links returned "Nothing found" on 10 October, so we could not read the full text.
What buyers say on Reddit
The recent threads are mostly about SARMs and MK-677, not peptides, and none mentions either domain by name.
- A 28 September 2026 post in r/SARMsTalk says an MK-677 order did nothing and that support "tried intimidating me, by saying it'll destroy my credit score if I charge back" (thread). The poster had no lab test. The top reply asked whether it was tested, since "you might just be a non responder."
- A 17 September post in r/suppgains says "Swiss has been getting a lot of bad reviews lately" (thread).
- A 9 October post in r/SARMsTalk calls Swiss Chems "great" but notes it does not stock LGD-4033 (thread).
- On 9 October the same account posted in r/BodyHackGuide (thread) and r/SARMsTalk (thread) asking whether Swiss Chems can be trusted, saying the aim was to buy orforglipron and that the poster had found only three complaints from over a year ago. That is demand for the orforglipron listing, not evidence about it.
- An 11 October post in r/SARMsTalk asks what "0 of 17 checks documented" means for a Swiss Chems MK-677 batch (thread). The replies are one-liners ("Mine was good", "Prob not") and none cites a lab test. We could not tell which rating site the poster was quoting.
Your card issuer and the card network set chargeback rules, not the shop. Read your issuer's dispute terms before you decide.
How we scored Swiss Chems
| Subscore | Weight | Score | Main reason |
|---|---|---|---|
| COA quality | 40% | 5.0 | Finnrick 4 of 10 pass; no records in our Janoshik or Kovera mirrors; some reports name another client; past mis-filed certificates |
| Pricing | 25% | 7.9 | Unchanged from our June price capture; we did not re-run the index for this update |
| Shipping | 20% | 7.0 | Published carriers and timeframes; no order of ours |
| Support | 15% | 5.0 | Reddit chargeback complaint; refund and terms pages missing; a lookalike trading on the name |
The weighted subscores come to 6.1. We take 1.5 off for an open FDA warning letter, the same deduction as Peptide Partners; Hello Stacks, with no letter, lost 0.5. We treat a letter as open until FDA posts a close-out letter, and FDA's page for letter 695663 showed no response or close-out letter on 10 October 2026. The named drugs are off the site now, but retatrutide was still on sale in June 2026, 18 months after the letter, and the shop now lists orforglipron and prescription drugs as "research" capsules. That gives 4.6. The rubric is on our methodology page.
FAQ
Is swisschemzlab.com the real Swiss Chems? We found no evidence that it is. swisschemzlab.com was registered on 13 September 2026 and says Swiss Chems "now operates" there, but swisschems.is is still live, still taking orders and does not mention a move. FDA's 2024 letter, Finnrick and our own records all point to swisschems.is. We would not pay swisschemzlab.com on this evidence.
What is the official Swiss Chems website? swisschems.is. It is the domain FDA named in its December 2024 warning letter, the address its support email uses, and the site our certificate mirror and price captures have read since May 2026. Its .is registration dates from June 2020. An older swisschems.com, registered in 2018, is now parked.
Is Swiss Chems legit? It is a long-running shop, with certificate files back to 2018, but its record is weak. Finnrick recorded 4 passes in 10 samples (a 47% rating), FDA sent it a warning letter in December 2024, it still listed retatrutide in June 2026, and it now lists orforglipron, the active ingredient of an FDA-approved drug. We score it 46/100.
Did the FDA shut down Swiss Chems? No. FDA sent warning letter 695663 on 10 December 2024 over semaglutide and retatrutide listings. A warning letter is not a shutdown order. swisschems.is was trading on 10 October 2026. Its semaglutide, retatrutide and tirzepatide pages were gone by then; we recorded retatrutide on sale as late as 23 June 2026.
Why is everyone searching for Swiss Chems right now? We don't know. Google Trends shows "swisschems" breaking out (+11,050%) in US related searches for BPC-157 over the week to 10 October 2026, from near zero in late September. The lookalike domain, Chemyo's closure and a Reddit complaint all landed in the same weeks. None is confirmed as the cause.
Does vialaudit earn commission from Swiss Chems? No, not any more. We ended the affiliate link and the VIALAUDIT10 code on 13 October 2026 and removed Swiss Chems from the ranked vendor list. The link to swisschems.is on this page is a plain link. We have no relationship with swisschemzlab.com.
What we read, and what we did not
Read on 10 October 2026: the homepages, about pages and test-results pages of swisschems.is and swisschemzlab.com; swisschemzlab.com's FDA explainer; the swisschems.is shipping page and orforglipron product page; RDAP records for swisschems.is, swisschemzlab.com and swisschems.com; Wayback Machine capture lists for swisschemzlab.com and swisschems.com; FDA warning letter 695663; Finnrick's Swiss Chems page; three Freedom Diagnostics PDFs; three Reddit threads.
Re-checked on 12 October 2026: FDA's page for letter 695663 (no response or close-out letter shown); the shop's store listing for orforglipron and for semaglutide, retatrutide and tirzepatide; Finnrick's Swiss Chems page (unchanged at 47%, 4 of 10 passed, #447 of 457); the swisschems.is FAQ, payment and test-results pages; swisschemzlab.com (still live); and three more Reddit threads.
From our own records: the May 2026 crawl of 89 certificates from swisschems.is, the 23 June 2026 price capture, and our Janoshik (337 readable reports, 364 indexed) and Kovera (1,828) mirrors.
Not read: the Wayback capture list for swisschems.is (the archive was offline when we tried); the full refund policy and terms (both links returned "Nothing found"); any order of our own. We did not contact either site.
Related
Catalog COA record
VENDOR-PUBLISHED · US-CERTIFIED THIRD-PARTY LABORATORY (HPLC-UV / LC-MS)Aggregated from Swiss Chems's published Certificates of Analysis. Lab work: US-certified third-party laboratory (HPLC-UV / LC-MS). Most recent test on file: APR 2026. Click any compound row to expand the batch-level table.
ARA2901 BATCHMEDIAN —
BAM-151 BATCHMEDIAN 99.60%
BPC-1574 BATCHESMEDIAN 98.80%
CJC-1295 (with DAC)2 BATCHESMEDIAN 99.55%
CJC-1295 (without DAC)2 BATCHESMEDIAN 99.84%
CJC-1295 with DAC3 BATCHESMEDIAN 99.38%
Clomiphene1 BATCHMEDIAN —
Dihexa4 BATCHESMEDIAN 98.81%
Enclomiphene2 BATCHESMEDIAN —
Epitalon2 BATCHESMEDIAN 99.80%
GHK-Cu1 BATCHMEDIAN 99.99%
GW-501516 (Cardarine)2 BATCHESMEDIAN 99.35%
GW5015162 BATCHESMEDIAN —
HCG2 BATCHESMEDIAN —
HMG (Human Menopausal Gonadotropin)2 BATCHESMEDIAN —
IGF-1 DES2 BATCHESMEDIAN 98.20%
IGF-1 LR33 BATCHESMEDIAN 99.00%
Ipamorelin6 BATCHESMEDIAN 99.60%
Kisspeptin-102 BATCHESMEDIAN 99.80%
MK-6772 BATCHESMEDIAN —
MOTS-C3 BATCHESMEDIAN 99.62%
Melanotan II5 BATCHESMEDIAN 99.46%
Methylene Blue4 BATCHESMEDIAN —
Mirabegron1 BATCHMEDIAN —
NSI-189 Phosphate2 BATCHESMEDIAN —
Noopept2 BATCHESMEDIAN 98.67%
PRL-8-532 BATCHESMEDIAN 99.52%
PT-141 (Bremelanotide)2 BATCHESMEDIAN 99.80%
Phenibut FAA4 BATCHESMEDIAN 98.86%
Phenibut HCl2 BATCHESMEDIAN 99.85%
RAD-140 (Testolone)2 BATCHESMEDIAN 99.36%
S232 BATCHESMEDIAN —
SLU-PP-3322 BATCHESMEDIAN 99.64%
Sermorelin4 BATCHESMEDIAN 99.68%
Tesamorelin2 BATCHESMEDIAN 99.20%
Tesofensine2 BATCHESMEDIAN 99.56%
Sources
9 REFERENCES- Swiss Chems FAQ (testing statement, read 12 Oct 2026) — vendor
- Swiss Chems payment options (read 12 Oct 2026) — vendor
- FDA warning letter 695663, Swisschems, 10 December 2024 — FDA
- Finnrick vendor page, Swiss Chems — Finnrick
- Swiss Chems independent test results — vendor
- RDAP record, swisschemzlab.com — Verisign RDAP
- RDAP record, swisschems.is — ISNIC RDAP
- FDA approves Foundayo (orforglipron), 1 April 2026 — FDA
- FDA peptide enforcement, 2024-2026 — vialaudit